DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02268 WUXI XDC

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders [02269] WuXi Biologics (Cayman) Inc. (50.82%)
[02359] WuXi AppTec Company Limited (21.88%)
Sector Health Care & Biotechnology
Web Site http://www.wuxixdc.com Tel N/A
Email Wuxixdc.ir@wuxibiologics.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in research, discovery, development and manufacturing of the drug substances and drug products of antibody drug conjugates and other bioconjugates.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Central China Securities Co. Ltd. (中原證券股份有限公司) 118,000,000(L)  9.48(L)  01/11/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top